DISTURBED HANDLING OF ASCORBIC-ACID IN DIABETIC-PATIENTS WITH AND WITHOUT MICROANGIOPATHY DURING HIGH-DOSE ASCORBATE SUPPLEMENTATION

被引:120
作者
SINCLAIR, AJ
GIRLING, AJ
GRAY, L
LEGUEN, C
LUNEC, J
BARNETT, AH
机构
[1] UNIV BIRMINGHAM,ACAD DEPT GERIATR MED,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[2] UNIV BIRMINGHAM,DEPT MATH & STAT,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[3] UNIV BIRMINGHAM,DEPT MED,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[4] E BIRMINGHAM DIST GEN HOSP,BIRMINGHAM B9 5ST,W MIDLANDS,ENGLAND
关键词
ASCORBIC ACID; DEHYDROASCORBIC ACID; DIABETES MELLITUS; FREE RADICAL ACTIVITY; OXIDATIVE STRESS;
D O I
10.1007/BF00418271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abnormalities of ascorbic acid metabolism have been reported in experimentally-induced diabetes and in diabetic patients. Ascorbate is a powerful antioxidant, a co-factor in collagen biosynthesis, and affects platelet activation, prostaglandin synthesis and the polyol pathway. This suggests a possible close interrelationship between ascorbic acid metabolism and pathways known to be influenced by diabetes. We determined serum ascorbic acid and its metabolite, dehydroascorbic acid, as indices of antioxidant status, and the ratio, dehydroascorbate/ascorbate, as an index of oxidative stress, in 20 matched diabetic patients with and 20 without microangiopathy and in 22 age-matched control subjects. Each study subject then took ascorbic acid, 1 g daily orally, for six weeks with repeat measurements taken at three and six weeks. At baseline, patients with microangiopathy had lower ascorbic acid concentrations than those without microangiopathy and control subjects (42.1 +/- 19.3 vs 55.6 +/- 20.0, p < 0.01, vs 82.9 +/- 30.9-mu-mol/l, p < 0.001) and elevated dehydroascorbate/ascorbate ratios (0.87 +/- 0.46 vs 0.61 +/- 0.26, p < 0.01, vs 0.38 +/- 0.14, p < 0.001). At three weeks, ascorbate concentrations rose in all groups (p < 0.0001) and was maintained in control subjects (151.5 +/- 56.3-mu-mol/l), but fell in both diabetic groups by six weeks (p < 0.01). Dehydroascorbate/ascorbate ratios fell in all groups at three weeks (p < 0.0001) but rose again in the diabetic groups by six weeks (p < 0.001) and was unchanged in the control subjects. Dehydroascorbate concentrations rose significantly from baseline in all groups by six weeks of ascorbic acid supplementation (p < 0.05). No significant changes were observed in fructosamine concentrations in any group during the study. Diabetes mellitus is associated with a major disturbance of ascorbic acid metabolism which is only partially corrected by ascorbate supplementation.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 39 条
[1]   BLOOD DEHYDROASCORBIC ACID AND DIABETES-MELLITUS IN HUMAN-BEINGS [J].
BANERJEE, A .
ANNALS OF CLINICAL BIOCHEMISTRY, 1982, 19 (MAR) :65-70
[2]  
BARNES MJ, 1976, ANN NY ACAD SCI, V258, P264
[3]   INTERACTION BETWEEN GLUCOSE AND DEHYDROASCORBATE TRANSPORT IN HUMAN-NEUTROPHILS AND FIBROBLASTS [J].
BIGLEY, R ;
WIRTH, M ;
LAYMAN, D ;
RIDDLE, M ;
STANKOVA, L .
DIABETES, 1983, 32 (06) :545-548
[4]  
CAIRD FL, 1982, ADV GERIATRIC MED, P3
[5]   HYPERGLYCEMIA-INDUCED INTRACELLULAR DEPLETION OF ASCORBIC-ACID IN HUMAN MONONUCLEAR LEUKOCYTES [J].
CHEN, MS ;
HUTCHINSON, ML ;
PECORARO, RE ;
LEE, WYL ;
LABBE, RF .
DIABETES, 1983, 32 (11) :1078-1081
[6]   FREE-RADICAL ACTIVITY IN TYPE-2 DIABETES [J].
COLLIER, A ;
WILSON, R ;
BRADLEY, H ;
THOMSON, JA ;
SMALL, M .
DIABETIC MEDICINE, 1990, 7 (01) :27-30
[7]   VITAMIN-C SUPPLEMENTS AND DIABETIC CUTANEOUS CAPILLARY FRAGILITY [J].
COX, BD ;
BUTTERFIELD, WJH .
BRITISH MEDICAL JOURNAL, 1975, 3 (5977) :205-205
[8]   POTENTIAL CLINICAL-APPLICATIONS FOR HIGH-DOSE NUTRITIONAL ANTIOXIDANTS [J].
CRARY, EJ ;
MCCARTY, MF .
MEDICAL HYPOTHESES, 1984, 13 (01) :77-98
[9]  
DAVIS KA, 1983, FED PROC, V42, P2011
[10]   THE DISTRIBUTION OF ASCORBIC-ACID BETWEEN VARIOUS CELLULAR-COMPONENTS OF BLOOD, IN NORMAL INDIVIDUALS, AND ITS RELATION TO THE PLASMA-CONCENTRATION [J].
EVANS, RM ;
CURRIE, L ;
CAMPBELL, A .
BRITISH JOURNAL OF NUTRITION, 1982, 47 (03) :473-482